Casanova, I.; Domínguez-Mozo, M.I.; De Torres, L.; Aladro-Benito, Y.; García-Martínez, Á.; Gómez, P.; Abellán, S.; De Antonio, E.; Álvarez-Lafuente, R.
MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate. Biomedicines 2023, 11, 2760.
https://doi.org/10.3390/biomedicines11102760
AMA Style
Casanova I, Domínguez-Mozo MI, De Torres L, Aladro-Benito Y, García-Martínez Á, Gómez P, Abellán S, De Antonio E, Álvarez-Lafuente R.
MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate. Biomedicines. 2023; 11(10):2760.
https://doi.org/10.3390/biomedicines11102760
Chicago/Turabian Style
Casanova, Ignacio, María I. Domínguez-Mozo, Laura De Torres, Yolanda Aladro-Benito, Ángel García-Martínez, Patricia Gómez, Sara Abellán, Esther De Antonio, and Roberto Álvarez-Lafuente.
2023. "MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate" Biomedicines 11, no. 10: 2760.
https://doi.org/10.3390/biomedicines11102760
APA Style
Casanova, I., Domínguez-Mozo, M. I., De Torres, L., Aladro-Benito, Y., García-Martínez, Á., Gómez, P., Abellán, S., De Antonio, E., & Álvarez-Lafuente, R.
(2023). MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate. Biomedicines, 11(10), 2760.
https://doi.org/10.3390/biomedicines11102760